A share price of InMed Pharmaceuticals Inc [INM] is currently trading at $0.37, up 8.86%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The INM shares have gain 5.71% over the last week, with a monthly amount glided 10.12%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
On 4, April 2024, InMed’s INM-901 Demonstrates Favorable Pharmacological and Behavioral Effects in In Vivo Preclinical Alzheimer’s Disease Studies. In a post published today on Yahoo Finance, INM-901 receptor binding studies indicate preferential signaling agonism for CB1/CB2 and impacts the PPAR signaling pathway.
From an analyst’s perspective:
InMed Pharmaceuticals Inc experienced fluctuations in its stock price throughout the past year between $0.29 and $2.08. InMed Pharmaceuticals Inc [NASDAQ: INM] shares were valued at $0.37 at the most recent close of the market.
Analyzing the INM fundamentals
Trailing Twelve Months sales for InMed Pharmaceuticals Inc [NASDAQ:INM] were 5.49M which represents 163.99% growth. Gross Profit Margin for this corporation currently stands at 0.34% with Operating Profit Margin at -1565.5%, Pretax Profit Margin comes in at -1.01%, and Net Profit Margin reading is -1.01%. To continue investigating profitability, this company’s Return on Assets is posted at -0.42, Equity is -0.54 and Total Capital is -723.62. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.09.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.3313 points at the first support level, and at 0.2925 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.3924, and for the 2nd resistance point, it is at 0.4147.
InMed Pharmaceuticals Inc [INM] reported earnings per share of -$14.03 for its fiscal quarter that ended on 6/29/2022. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of -$5.5/share, meaning a difference of -$8.53 and a surprise factor of -155.10%. By comparison, the stated earnings for the previous quarter ended on 3/30/2022 were -$6.25 per share as compared to estimates of -$6.25 per share, a difference of $0 representing a surprise of 0.00%.
Ratios To Look Out For
To put it in perspective, the Current Ratio for InMed Pharmaceuticals Inc [NASDAQ:INM] is 7.03. As well, the Quick Ratio is 6.58, while the Cash Ratio is 5.67. Considering the valuation of this stock, the price to sales ratio is 0.22, the price to book ratio is 0.16.
Transactions by insiders
Recent insider trading involved HULL ANDREW, Director, that happened on Feb 21 ’24 when 37500.0 shares were purchased. President & CEO, ADAMS ERIC A completed a deal on Feb 20 ’24 to buy 41600.0 shares.
